China's 11th nationwide centralized drug procurement round has selected 55 medicines, including antivirals and diabetes treatments, which are expected to become available at lower prices from February 2026, theNational Healthcare Security Administration said last week. 國家醫療保障局上週表示，我國第十一批全國藥品集中采購已敲定55個品種，涵蓋抗病毒、糖尿病治療等多類用藥，預計2026年2月起落地執行，價格將顯著下降。 Preliminary results from the bidding process, held in Shanghai on Oct 27, show that the chosen drugs cover a wide range of therapeutic areas such as infections, allergies, cancers, high blood pressure, high cholesterol, high blood sugar,inflammation and pain relief. 10月27日在上海完成的競標結果初步顯示，中選藥品覆蓋感染、過敏、腫瘤、高血壓、高血脂、高血糖、炎症及鎮痛等廣泛治療領域。 Among the successful bids are the flu drug oseltamivir, a first-line diabetes medication called metformin and targeted cancer drug olaparib. 流感藥物奧司他韋、一線糖尿病用藥二甲雙胍以及抗癌靶向藥奧...